Yamado K,Hino K,Tomoyasu S,et al. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture[J]. Leuk Res,1998,22: 589.
[3]
Yeh J Y,Huang W J,Kan S F,et al. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells[J]. Prostate,2003,54: 112.
[4]
Kruger N J. The bradford method for protein quantitation[J]. Methods Mol Biol,1994,32(1): 9.
[5]
Ma C,Liu X,Yue Q X,et al. Proteomic analysis of possible target-related proteins of cyclophosphamide in mice thymus[J]. Food Chem Toxicol,2009,47: 1841.
[6]
Yue Q X,Cao Z W,Liu X,et al. Proteomic characterization of the cytotoxic mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network[J]. Mol Cell Proteomics,2008,7:949.
Sewer M B,Li D. Regulation of steroid hormone biosynthesis by the cytoskeleton[J]. Lipids,2008,43(12): 1109.
[9]
Arends M J,Mortis R,Wyllie A H. Apoptosis:the role of the endonuclease[J]. Am Pathol,1990,136(3): 593.
[10]
Dai S,Jia Y,Wu S L,et al. Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin[J]. J Res Articles Proteome Res,2008,7(10): 4384.
[11]
Clarke E J,Allan V. Intermediate filaments:vimentin moves in[J]. Curr Biol,2002,12(17): R596.
[12]
Morishima N. Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action[J]. Genes Cells,1999,4(7): 401.
[13]
Byun Y,Chen F,Chang R,et al. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis[J]. Cell Death Differ,2001,8(5): 443.
Concannon C G,Orrenius S,Samali A. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both procaspase-3 and cytochrome[J]. Gene Expr,2001,9(4/5): 195.
[16]
Mario Notari, Paolo Neviani, Ramasamy Santhanam, et al. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation[J]. Blood, 2006, 107(6): 2507.
[17]
Papagiannakopoulos T,Shapiro A,Kosik K S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells[J]. Cancer Res,2008,68(19): 8164.
[18]
Ostareck-Lederer A,Ostareck D H,Cans C,et al. C-src-mediated phosphorylation of hnRNPK drives translational activation of specifically silenced mRNAs[J]. Mol Cell Biol,2002,22(13): 4535.
[19]
Huang K C,Park D C,Ng S K,et al. Selenium binding protein 1 in ovarian cancer[J]. Int J Cancer,2006,118: 2433.
[20]
Kim H,Kang H J,You K T,et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival[J]. Proteomics,2006,6: 3466.
